10/05/2024  17:31:10 Var. -0.45 Volume Denaro20:46:03 Lettera20:46:03 Capitalizzazione di mercato Dividend Y. Rapporto P/E
74.55CHF -0.60% 112,840
Fatturato: 8.48 mill.
74.50Quantità in denaro: 13 -Quantità in lettera: 40 1.18 bill.CHF - 12.26

Descrizione business

Operating under the "Zur Rose" and "DocMorris" brands, the Swiss-based Zur Rose Group is one of Europe's leading online pharmacy and one of Switzerland's foremost wholesale suppliers to medical practitioners. With its business model, it offers high-quality, safe and cost-effective pharmaceutical care and thus contributes to reducing healthcare costs. It is also characterized by the continuous further development of digital services in the field of drug management in order to increase therapy safety. The creation of added value and a pronounced patient orientation make the Group an important strategic partner for service providers, cost units and industry. The Zur Rose Group serves the Swiss market from Frauenfeld, Switzerland. In Germany and Austria, the Group operates through subsidiaries in Heerlen (Netherlands) and Halle an der Saale (Germany). Furthermore, it holds a majority interest in BlueCare in Winterthur, one of the leading providers of networking systems in the Swiss healthcare market.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Walter Hess
Consiglio di amministrazione
Marcel Ziwica, David Masó, Madhu Nutakki, Matthias Peuckert, Kaspar Niklaus
Consiglio di sorveglianza
Dr. Christian Mielsch, Florian Seubert, Prof. Dr. Andréa Belliger, Prof. Dr. Volker Amelung, Prof. Stefan Feuerstein, Walter Oberhänsli
 

Dati aziendali

Name: Zur Rose Group AG
Indirizzo: Walzmühlestrasse 60,CH-8500 Frauenfeld
Telefono: +41-52-7240020
Fax: +41-52-7240015
E-mail: info@zurrose.com
Internet: www.zurrosegroup.com
Industria: Consumer Goods
Settore: Retailers
Sub settore: -
Fine dell'anno finanziario: 31/12
Flottante libero: 75.60%
Data dell'IPO: 06/07/2017

Rapporti con gli investitori

Name: Marcel Ziwica
IR telefono: +41-52-7240064
IR Fax: -
IR e-mail: marcel.ziwica@zurrose.com

Company calendar

CW 34 | 20/08/2024 Interim Report 2nd Quarter/6 Months
CW 42 | 15/10/2024 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

Altri
 
85.37%
Frank M. Sands
 
4.93%
Patrick Schmitz-Morkramer Patrick Bierbaum
 
3.79%
Benjamin Leslie Levine
 
3.02%
BlackRock, Inc
 
2.89%